Page 84 - ESHRE2019

Is anti HCV Antibody a suitable test?
No: NAT testing is preferable
Empowering the freedom of reproductive choice with wisdo
m
Concerns regarding Viral Screening
 Aims: to reduce risk (to staff, patients and offspring) Cost implications:
900,000 ART cycles in Europe per year equate to a cost of 140 million Euros per year for screening (excluding admin costs) based on a 100 Euros per test kit
Frequency of screening: arbitary
Only robust method: NAT testing of all cases on day of VEC Prohibited by cost and practical issues
Empowering the freedom of reproductive choice with wisdo
m
82
79